DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,430,373 | +6.6% | 38,019 | +3.1% | 0.17% | +5.0% |
| Q2 2023 | $8,845,581 | +8.6% | 36,863 | +14.1% | 0.16% | +3.9% |
| Q1 2023 | $8,141,561 | -3.4% | 32,314 | +1.8% | 0.15% | -11.0% |
| Q4 2022 | $8,423,923 | +4.0% | 31,753 | +1.2% | 0.17% | -3.4% |
| Q3 2022 | $8,103,000 | +6.9% | 31,370 | +4.9% | 0.18% | +12.6% |
| Q2 2022 | $7,581,000 | -16.3% | 29,903 | -3.2% | 0.16% | 0.0% |
| Q1 2022 | $9,057,000 | -17.3% | 30,876 | -7.2% | 0.16% | -18.5% |
| Q4 2021 | $10,951,000 | -3.5% | 33,285 | -10.7% | 0.20% | -4.9% |
| Q3 2021 | $11,347,000 | +20.1% | 37,272 | +5.9% | 0.20% | +12.6% |
| Q2 2021 | $9,447,000 | +5.0% | 35,204 | -11.9% | 0.18% | -8.5% |
| Q1 2021 | $8,998,000 | +2.3% | 39,978 | +1.0% | 0.20% | -6.1% |
| Q4 2020 | $8,795,000 | +77.6% | 39,594 | +72.2% | 0.21% | +41.3% |
| Q3 2020 | $4,951,000 | +17.7% | 22,994 | -3.3% | 0.15% | +4.2% |
| Q2 2020 | $4,206,000 | +71.5% | 23,785 | +48.9% | 0.14% | +118.2% |
| Q4 2019 | $2,452,000 | +56.0% | 15,974 | +46.8% | 0.07% | +17.9% |
| Q3 2019 | $1,572,000 | +11.8% | 10,882 | +8.1% | 0.06% | +7.7% |
| Q2 2019 | $1,406,000 | -4.2% | 10,063 | -9.5% | 0.05% | -16.1% |
| Q1 2019 | $1,468,000 | +74.3% | 11,118 | +36.2% | 0.06% | +67.6% |
| Q4 2018 | $842,000 | -4.4% | 8,164 | +0.7% | 0.04% | +5.7% |
| Q3 2018 | $881,000 | +8.5% | 8,107 | -1.5% | 0.04% | -2.8% |
| Q2 2018 | $812,000 | -2.8% | 8,231 | -3.4% | 0.04% | -10.0% |
| Q1 2018 | $835,000 | +21.0% | 8,525 | +14.7% | 0.04% | +17.6% |
| Q4 2017 | $690,000 | +20.4% | 7,431 | +11.3% | 0.03% | +9.7% |
| Q3 2017 | $573,000 | +1.4% | 6,675 | -0.3% | 0.03% | -11.4% |
| Q2 2017 | $565,000 | +7.0% | 6,693 | +8.4% | 0.04% | +2.9% |
| Q1 2017 | $528,000 | +8.4% | 6,172 | -1.4% | 0.03% | -8.1% |
| Q4 2016 | $487,000 | +5.6% | 6,259 | +6.5% | 0.04% | -11.9% |
| Q3 2016 | $461,000 | -81.4% | 5,876 | -80.9% | 0.04% | -84.3% |
| Q2 2016 | $2,483,000 | -18.9% | 30,797 | -4.5% | 0.27% | -23.3% |
| Q1 2016 | $3,061,000 | +5.1% | 32,265 | -1.9% | 0.35% | +8.8% |
| Q4 2015 | $2,912,000 | +6.2% | 32,904 | +2.2% | 0.32% | -15.6% |
| Q3 2015 | $2,742,000 | -13.4% | 32,182 | -13.0% | 0.38% | +1.9% |
| Q2 2015 | $3,165,000 | +5.0% | 36,978 | +4.1% | 0.37% | +9.1% |
| Q1 2015 | $3,015,000 | -4.3% | 35,514 | -3.4% | 0.34% | +1.8% |
| Q4 2014 | $3,150,000 | +8.6% | 36,750 | -3.7% | 0.34% | +12.8% |
| Q3 2014 | $2,901,000 | -4.2% | 38,181 | -0.7% | 0.30% | -1.7% |
| Q2 2014 | $3,028,000 | +5.9% | 38,456 | +0.9% | 0.30% | +3.8% |
| Q1 2014 | $2,859,000 | -0.5% | 38,114 | +2.4% | 0.29% | +1.7% |
| Q4 2013 | $2,874,000 | +13.0% | 37,229 | +1.5% | 0.29% | +7.9% |
| Q3 2013 | $2,544,000 | +9.4% | 36,694 | -0.1% | 0.26% | -6.4% |
| Q2 2013 | $2,325,000 | – | 36,728 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |